Acute Rabbit Eye Model for Testing Subretinal Prostheses.

rabbit eye model acute visual electrophysiology eye model longitudinal OCT retinal prosthesis subretinal implantation

Journal

Translational vision science & technology
ISSN: 2164-2591
Titre abrégé: Transl Vis Sci Technol
Pays: United States
ID NLM: 101595919

Informations de publication

Date de publication:
Sep 2019
Historique:
received: 06 02 2019
accepted: 23 07 2019
entrez: 12 10 2019
pubmed: 12 10 2019
medline: 12 10 2019
Statut: epublish

Résumé

Subretinal prostheses are a novel technology for restoring useful vision in patients with retinitis pigmentosa or age-related macular degeneration. We characterize the surgical implantation technique and functional time window of an acute rabbit eye model for testing of human subretinal prostheses. Retinal prostheses were implanted subretinally in 26 rabbits using a two-step technique. Fundus imaging, fluorescein fundus angiography, and optical coherence topography (OCT) were conducted postoperatively from days 1 to 21 to monitor prosthesis positioning and retinal anatomic changes. Successful implantation and excellent retina apposition were achieved in 84.6% of the rabbits. OCTs showed the overlying retina at full thickness for the first 2 days after implantation. Histology confirmed intact inner layers of the overlying retina until day 3. Progressive atrophy of the overlying retina was revealed by repeated OCTs; approximately 40% of the retina thickness remained on postoperative days 5 and 6. The two-step implantation technique works well for the rabbit eye model with human prostheses. Rabbit retina may be used for acute electrophysiologic testing of a retinal prosthesis, but is unsuitable for chronic studies due to the merangiotic retina and its limited time window of validity. The improved efficacy in prosthesis surgery using this technique will circumvent the challenges in animal models that provide human-like features critical for the transition into human clinical trials.

Identifiants

pubmed: 31602345
doi: 10.1167/tvst.8.5.20
pii: TVST-19-1404
pmc: PMC6779096
doi:

Types de publication

Journal Article

Langues

eng

Pagination

20

Subventions

Organisme : NEI NIH HHS
ID : P30 EY022589
Pays : United States

Informations de copyright

Copyright 2019 The Authors.

Références

Neurosci Lett. 1997 Mar 28;225(1):13-6
pubmed: 9143006
Graefes Arch Clin Exp Ophthalmol. 2004 Sep;242(9):792-9
pubmed: 15179515
Graefes Arch Clin Exp Ophthalmol. 2007 Aug;245(8):1169-78
pubmed: 17219111
IEEE Trans Biomed Eng. 2009 Oct;56(10):2502-11
pubmed: 19403357
Prog Retin Eye Res. 2018 Jan;62:1-23
pubmed: 29042326
Invest Ophthalmol Vis Sci. 1999 Jan;40(1):143-8
pubmed: 9888437
Invest Ophthalmol Vis Sci. 2016 Nov 1;57(14):6147-6157
pubmed: 27835711
Am J Ophthalmol. 2018 Sep;193:87-99
pubmed: 29940167
Trends Biotechnol. 2013 Oct;31(10):562-71
pubmed: 23953722
Prog Retin Eye Res. 2007 Jul;26(4):437-51
pubmed: 17512238
Ophthalmic Res. 2009;42(3):128-37
pubmed: 19590253
Biomed Opt Express. 2015 Dec 04;7(1):13-21
pubmed: 26819813
Prog Retin Eye Res. 2017 May;58:1-27
pubmed: 28111323
Invest Ophthalmol Vis Sci. 2018 Dec 3;59(15):5885-5892
pubmed: 30550611
Arch Ophthalmol. 1997 Apr;115(4):511-5
pubmed: 9109761
Prog Retin Eye Res. 2016 Jan;50:89-107
pubmed: 26404104
IEEE Trans Biomed Eng. 2014 May;61(5):1412-24
pubmed: 24710817
J Neural Eng. 2016 Oct;13(5):056008
pubmed: 27529371
J Chin Med Assoc. 2015 Sep;78(9):501-5
pubmed: 26142056
Graefes Arch Clin Exp Ophthalmol. 2008 Nov;246(11):1505-17
pubmed: 18709385
Jpn J Ophthalmol. 2010 Sep;54(5):467-75
pubmed: 21052911
Invest Ophthalmol Vis Sci. 2013 May 01;54(5):3751-62
pubmed: 23611996
Biomaterials. 2002 Feb;23(3):797-804
pubmed: 11771699
Graefes Arch Clin Exp Ophthalmol. 2001 Dec;239(12):961-7
pubmed: 11820703
Lancet. 2006 Nov 18;368(9549):1795-809
pubmed: 17113430
Graefes Arch Clin Exp Ophthalmol. 2004 Jul;242(7):587-96
pubmed: 15197555
Arch Ophthalmol. 1985 Sep;103(9):1382-4
pubmed: 4038132
Klin Monbl Augenheilkd. 2016 Nov;233(11):1227-1232
pubmed: 27676329
J Neural Eng. 2005 Mar;2(1):S48-56
pubmed: 15876654
Vision Res. 2015 Jun;111(Pt B):149-60
pubmed: 25812924
Ophthalmic Surg Lasers Imaging Retina. 2016 Feb;47(2):171-4
pubmed: 26878451
Conf Proc IEEE Eng Med Biol Soc. 2011;2011:7492-5
pubmed: 22256071
Ophthalmology. 2011 Nov;118(11):2227-37
pubmed: 22047893
Ophthalmology. 2015 Oct;122(10):2114
pubmed: 26398053

Auteurs

Ying Xiao (Y)

Department of Ophthalmology, Jacobs Retina Center at Shiley Eye Institute, University of California, San Diego, La Jolla, CA, USA.

Yuqin Wang (Y)

Department of Ophthalmology, Jacobs Retina Center at Shiley Eye Institute, University of California, San Diego, La Jolla, CA, USA.

Fangting Li (F)

Department of Ophthalmology, Jacobs Retina Center at Shiley Eye Institute, University of California, San Diego, La Jolla, CA, USA.

Tiezhu Lin (T)

Department of Ophthalmology, Jacobs Retina Center at Shiley Eye Institute, University of California, San Diego, La Jolla, CA, USA.

Kristyn Huffman (K)

Department of Ophthalmology, Jacobs Retina Center at Shiley Eye Institute, University of California, San Diego, La Jolla, CA, USA.

Stephanie Landeros (S)

Department of Ophthalmology, Jacobs Retina Center at Shiley Eye Institute, University of California, San Diego, La Jolla, CA, USA.

Brandon Bosse (B)

Nanovision Biosciences, Inc., La Jolla, CA, USA.

Yi Jing (Y)

Nanovision Biosciences, Inc., La Jolla, CA, USA.

Dirk-Uwe Bartsch (DU)

Department of Ophthalmology, Jacobs Retina Center at Shiley Eye Institute, University of California, San Diego, La Jolla, CA, USA.

Scott Thorogood (S)

Nanovision Biosciences, Inc., La Jolla, CA, USA.

William R Freeman (WR)

Department of Ophthalmology, Jacobs Retina Center at Shiley Eye Institute, University of California, San Diego, La Jolla, CA, USA.

Lingyun Cheng (L)

Department of Ophthalmology, Jacobs Retina Center at Shiley Eye Institute, University of California, San Diego, La Jolla, CA, USA.

Classifications MeSH